Editas Medicine reports Q4 loss of $0.06/share, narrower tha
Editas Medicine, Inc. (EDIT) reported a Q4 2025 loss of $0.06 per share, narrower by 72.1% compared to the consensus ...
Thursday, August 6, 2026
Tag: Editas
Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.